BEAM Stock Performance and Key Statistics

BEAM has a current P/E ratio of -39.47

The BEAM stock has a trailing twelve month price-to sales (P/S) ratio of 22.37 while its price-to-book (P/B) value is 2.55.

BEAM's price-to-free-cashflow (P/FCF) ratio is -8.68, an indicator that is currently being trending upward.

Based on BEAM's recent bid, its distance from 20 days simple moving average is 4.09%. It is 0.76% apart from 50 days simple moving average, and it is 25.78% apart from 200 days simple moving average.

The 52-week high for BEAM is $36.44 which is -20.64% away from the current price level whereas the distance of that from the 52-week low of $15.35 stands at 113.83%.

The performance of BEAM stock was not encouraging with most of its significant price indicators in green. Beam Therapeutics Inc.(NASDAQ: BEAM) shares have moved upward +3.26% or $1.00 in the latest trading session and have gained 11.71% year-to-date (YTD). The stock has gained nearly 32.33% over the past year. After moving 19.19% over the trailing 3-month period, the stock is 47.24% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -8.09% a week and 20.96% a month.

The current 14-day RSI for BEAM stock is 51.42. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Beam Therapeutics Inc. (BEAM) has a 14-day ATR of 2.17.

After closing at $30.69 with 101.86M of its shares outstanding, the current enterprise value of BEAM is roughly 1.59B.

Beam Therapeutics Inc. (NASDAQ: BEAM) is up 32.33% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 24.91%. BEAM stock price is also up 11.71% on its value in year-to-date trading.

The number outstanding shares of BEAM is 101.86M, and of these 86.02% shares are freely available for trading. On average, BEAM stock has traded 1.66M shares per day for the past 10 days. A total of 1.66M shares changed hands during the last trading session with the average session volume of 1.9M shares.